The
global Pacemaker Market size is expected to reach USD
10.3 billion by 2025, according to a new report by Grand View Research, Inc.,
exhibiting a 7.2% CAGR during the forecast period. Heightening prevalence of
cardiac conditions, coupled with rising availability of medical coverage, is a
key driving factor governing the growth of the pacemaker market globally. In
addition, technological enhancements in these devices are supporting market
expansion.
Increasing
prevalence of cardiovascular diseases (CVDs) is a high-impact growth-rendering
factor. The World Health Organization reported an estimated 17.5 million deaths
stemming from CVDs in 2012. Currently, high occurrence of CVDs is a key concern
and in order to address this, government organizations and market participants
are channelizing funds and efforts to offer the best possible cure. This is
anticipated to foster R&D initiatives and increase the influx of advanced
products in this marketspace.
Additionally,
increasing awareness about cardiovascular disorders and their long-term impact
is raising the preference of patients for advanced treatment options. This is
expected to bolster the usage rate of these products. On the other hand, these
devices are cost prohibitive, with the price of a pacemaker ranging from USD
10,000 to USD 30,000. This is likely to restrain the growth of the market.
Browse
Details of Report @
https://www.grandviewresearch.com/industry-analysis/pacemaker-market
https://www.grandviewresearch.com/industry-analysis/pacemaker-market
Further
key findings from the study suggest:
- Implantable pacemakers held a lucrative share in 2016 and are
likely to grow at a profitable rate over the forecast period
- North America, owing to its planned healthcare network, greater per
capita income, and increasing awareness levels about adverse effects of a
prolonged cardiac condition, has retained a large share in the global
pacemaker market
- Economic development in countries such as India and China, unmet
needs of a massive population, and supportive initiatives undertaken by
governments to improve healthcare access are projected to present avenues
for investment in the Asia Pacific market
- Some of the key players operating in this space are Medtronic;
BIOTRONIK, Inc.; Boston Scientific Corporation; St. Jude Medical; ZOLL
Medical Corporation; MEDICO S.p.A.; Vitatron; Pacetronix; and Cordis, Inc.
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
Blog: https://healthcareforecastreport.blogspot.com/
No comments:
Post a Comment